Trademark applications and grants for Biocryst Pharmaceuticals, Inc.. Biocryst Pharmaceuticals, Inc. has 38 trademark applications. The latest application filed is for "BCRX"
State Incorporated | DELAWARE |
Entity Type | CORPORATION |
Address | 4505 Emperor Boulevard, Suite 200 Durham, NORTH CAROLINA UNITED STATES 27703 |
Patent Application | Date |
---|---|
PROCESS-SCALE SYNTHESIS OF A PLASMA KALLIKREIN INHIBITOR 20220289683 - 17/632585 El-Kattan; Yahya ;   et al. | 2022-09-15 |
DOSING REGIMENS FOR ORAL COMPLEMENT FACTOR D INHIBITORS 20220257556 - 17/630692 Babu; Yarlagadda S. ;   et al. | 2022-08-18 |
CRYSTALLINE SALTS OF A PLASMA KALLIKREIN INHIBITOR 20220204454 - 17/465181 El-Kattan; Yahya ;   et al. | 2022-06-30 |
PLASMA KALLIKREIN INHIBITORS AND METHODS OF USE THEREOF IN OCULAR DISORDERS 20220160694 - 17/602674 Babu; Yarlagadda ;   et al. | 2022-05-26 |
HUMAN PLASMA KALLIKREIN INHIBITORS 20220098151 - 17/374335 Kotian; Pravin L. ;   et al. | 2022-03-31 |
NCAGE Code | 4GBX7 | BIOCRYST PHARMACEUTICALS, INC. |
CAGE Code | 4GBX7 | BIOCRYST PHARMACEUTICALS, INC. |
S.A.M. Registration | 4GBX7 [618194609] | BIOCRYST PHARMACEUTICALS, INC. |
SEC | 0000882796 | BIOCRYST PHARMACEUTICALS INC of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.